| Date Filed | Type | Description |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/26/2023 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Disposed of 11,227 shares
@ $10.19, valued at
$114.4k
|
|
| 08/24/2023 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Disposed of 11,015 shares
@ $10.83, valued at
$119.3k
|
|
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Disposed of 11,749 shares
@ $11.79, valued at
$138.5k
|
|
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/31/2023 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Exercised 53,281 shares
@ $0
Disposed of 30,266 shares
@ $9.09, valued at
$275.1k
Exercised 170,464 options to buy
@ $6.4, valued at
$1.1M
|
|
| 05/30/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/25/2023 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Disposed of 18,972 shares
@ $9.58, valued at
$181.8k
|
|
| 05/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2023 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Disposed of 14,471 shares
@ $8.43, valued at
$122k
|
|
| 01/26/2023 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Disposed of 15,594 shares
@ $8.56, valued at
$133.5k
|
|
| 12/28/2022 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Disposed of 19,408 shares
@ $7.1, valued at
$137.8k
|
|
| 11/22/2022 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Disposed of 19,373 shares
@ $5, valued at
$96.9k
|
|
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2022 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Sold 21,053 shares
@ $3.07, valued at
$64.6k
|
|
| 08/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2022 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Sold 8,509 shares
@ $3.84, valued at
$32.7k
|
|
| 04/22/2022 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Granted 16,523,184 options to buy
@ $3.85, valued at
$63.6M
|
|
| 04/01/2022 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Sold 33,686 shares
@ $4.84, valued at
$163k
Paid exercise price by delivering 25,254 shares
@ $4.74, valued at
$119.7k
|
|
| 03/29/2022 |
4
| Gline Matthew (CEO) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Sold 35,386 shares
@ $5.06, valued at
$179.1k
|
|
| 03/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |